Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
Reported today (16 July 2018) in the journal Nature Biotechnology, the study also revealed that standard tests for detecting DNA changes miss finding this genetic damage, and that caution and specific testing will be required for any potential gene therapies.
CRISPR/Cas9 is one of the newest genome editing tools. It can alter sections of DNA in cells by cutting at specific points and introducing changes at that location. Already extensively used in scientific research, CRISPR/Cas9 has also been seen as a promising way to create potential genome editing treatments for diseases such as HIV, cancer or sickle cell disease. Such therapeutics could inactivate a disease-causing gene, or correct a genetic mutation. However, any potential treatments would have to prove that they were safe.
Previous research had not shown many unforeseen mutations from CRISPR/Cas9 in the DNA at the genome editing target site. To investigate this further the researchers carried out a full systematic study in both mouse and human cells and discovered that CRISPR/Cas9 frequently caused extensive mutations, but at a greater distance from the target site.
The researchers found many of the cells had large genetic rearrangements such as DNA deletions and insertions. These could lead to important genes being switched on or off, which could have major implications for CRISPR/Cas9 use in therapies. In addition, some of these changes were too far away from the target site to be seen with standard genotyping methods.
“This is the first systematic assessment of unexpected events resulting from CRISPR/Cas9 editing in therapeutically relevant cells, and we found that changes in the DNA have been seriously underestimated before now. It is important that anyone thinking of using this technology for gene therapy proceeds with caution, and looks very carefully to check for possible harmful effects.”
Professor Allan Bradley, corresponding author on the study from the Wellcome Sanger Institute
“My initial experiment used CRISPR/Cas9 as a tool to study gene activity, however it became clear that something unexpected was happening. Once we realised the extent of the genetic rearrangements we studied it systematically, looking at different genes and different therapeutically relevant cell lines, and showed that the CRISPR/Cas9 effects held true.”
Michael Kosicki, the first author from the Wellcome Sanger Institute
The work has implications for how CRISPR/Cas9 is used therapeutically and is likely to re-spark researchers’ interest in finding alternatives to the standard CRISPR/Cas9 method for gene editing.
“This study is the first to assess the repertoire of genomic damage arising at a CRISPR/Cas9 cleavage site. While it is not known if genomic sites in other cell lines will be affected in the same way, this study shows that further research and specific testing is needed before CRISPR/Cas9 is used clinically.”
Professor Maria Jasin, an independent researcher from Memorial Slone Kettering Cancer Centre, New York, who was not involved in the study
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- Cardea Bio and Nanosens Innovations Look to Combine Companieson September 6, 2019 at 5:27 am
There is global excitement for CRISPR-Chip, which combines Nanosens’ CRISPR-Cas9 nucleotide detecting technology and Cardea’s revolutionary graphene biosensor platform. By joining forces, the two ...
- Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elementson September 6, 2019 at 2:22 am
Pooled CRISPR-Cas9 screens are a powerful method for functionally characterizing regulatory elements in the non-coding genome, but off-target effects in these experiments have not been systematically ...
- CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulationon September 6, 2019 at 2:13 am
The introduction of insertion-deletions (INDELs) by non-homologous end-joining (NHEJ) pathway underlies the mechanistic basis of CRISPR-Cas9-directed genome editing. Selective gene ablation using ...
- Global Life Sciences Industry Report 2019: Examine 5 Key Predictions that will Shape the Marketon September 5, 2019 at 11:40 am
While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a ...
- The Swiss Army knife of gene editing gets new controlon September 5, 2019 at 4:49 am
When researchers want to edit, activate, or silence a gene in any living organism, from bacteria to humans, they often turn to CRISPR/Cas9, a complex of RNA and protein that can act like a genetic ...
- The first gene-edited lizard walks among uson September 4, 2019 at 2:44 pm
CRISPR-Cas9, a technology that allows scientists to edit an organism’s genes, has been used to do everything from experimenting with lab-grown meat to breeding climate-change resistant crops. Now, ...
- Image of the Day: Gene-Edited Reptileson September 4, 2019 at 5:08 am
For the first time, CRISPR-Cas9 has been used to create mutant reptiles, researchers reported August 27 in Cell Reports. Typically, scientists inject CRISPR-Cas9 gene-editing reagents into zygotes or ...
- Human flourishing in an age of gene editingon September 3, 2019 at 12:53 pm
The potential uses of gene-editing technologies such as Crispr-Cas9 are unprecedented in human history: they can make genetic alterations that would be passed down to future generations.
- CRISPR-Cas9 successfully reverses type 2 diabetes in miceon September 3, 2019 at 6:55 am
Researchers at Hanyang University, South Korea, have used the gene-editing technology CRISPR-Cas9 to treat obesity and type 2 diabetes in mice, a development that could eventually benefit humans. The ...
via Bing News